David George Lowe serves as Executive at ARCA biopharma, Inc., where they oversee executive responsibilities. Since joining the company, David George Lowe has executed 11 insider transactions totaling $1.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Apr 12, 2016 involved exercising options for 5,658 shares valued at $0.
David George Lowe currently holds 5,658 shares of ARCA biopharma, Inc. (ABIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David George Lowe has been a net seller of ABIO stock. They have purchased $0 and sold $1.7M worth of shares.
David George Lowe's most recent insider trade was on Apr 12, 2016, when they sold 5,658 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.94 |
| Discretionary |
| Jul 20, 2009 | ABIO | $452.9K | Sale | 102,000 | $4.44 | Discretionary |
| Jul 17, 2009 | ABIO | $104.8K | Sale | 25,000 | $4.19 | Discretionary |
| Jun 15, 2009 | ABIO | $23.8K | Sale | 6,100 | $3.90 | Discretionary |
| Jun 12, 2009 | ABIO | $15.0K | Sale | 3,800 | $3.94 | Discretionary |
| Jun 11, 2009 | ABIO | $156.3K | Sale | 40,700 | $3.84 | Discretionary |
| Jun 10, 2009 | ABIO | $142.6K | Sale | 36,000 | $3.96 | Discretionary |
| Jun 9, 2009 | ABIO | $189.5K | Sale | 47,500 | $3.99 | Discretionary |
| Jun 8, 2009 | ABIO | $276.6K | Sale | 65,708 | $4.21 | Discretionary |
| Jun 1, 2009 | ABIO | $0 | Other | 342,375 | $N/A | Discretionary |